TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32122177

Group type: EXPERIMENTAL
Intervention: WCDSAMCC
Number of subjects: 200

Group type: COMPARATOR
Intervention: SAS
Number of subjects: 200

Group type: COMPARATOR
Intervention: BS
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Other hair cleansing conditioners
Number of subjects: 200
Study: 34890060

Group type: EXPERIMENTAL
Intervention: Previsit Decision Aid (DA)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Within-visit Decision Aid (DA)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Previsit + Within-visit Decision Aid (DA)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 158
Study: 33800559

Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 105
Study: 32598699

Group type: EXPERIMENTAL
Intervention: Mechanical bacterial lysate (MBL) added to conventional therapy for COPD, 3 cycles of 10 days therapy with 20-day intervals between them.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional therapy for COPD without MBL (control group).
Number of subjects: 60
Study: 34379277

Group type: EXPERIMENTAL
Intervention: Multimodal strategies including clinician hypertension group‐based trainings, monthly clinician feedback reports, and monthly meetings with practice champions
Number of subjects: 4277

Group type: COMPARATOR
Intervention: Control periods
Number of subjects: 4277

Group type: EXPERIMENTAL
Intervention: Multimodal strategies
Number of subjects: 4277
Study: 33797058

Group type: EXPERIMENTAL
Intervention: Randomized single-case intervention designs
Number of subjects: 0
Study: 33011586

Group type: EXPERIMENTAL
Intervention: Telepractice
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-person therapy
Number of subjects: 20
Study: 35213754

Group type: EXPERIMENTAL
Intervention: Rumen-protected lysine (RPL) supplementation (80g daily from Day 21 before expected calving to parturition)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no RPL supplementation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rumen-protected lysine (RPL) supplementation
Number of subjects: 40
Study: 33641259

Group type: EXPERIMENTAL
Intervention: Pharmacogenomics guided treatment (n=105)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard antidepressant treatment (n=108)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 213
Study: 33962901

Group type: EXPERIMENTAL
Intervention: Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition indicators for the diagnosis of adult and pediatric malnutrition
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis measurement
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Registered dietitian nutritionist care
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Additional nutrition care and medical outcomes (eg, mortality and length of stay)
Number of subjects: 1200
Study: 33212440

Group type: EXPERIMENTAL
Intervention: 3-week self-guided, online cognitive behavioural intervention targeting dysfunctional COVID-19 worry and associated symptoms
Number of subjects: 670

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 670
Study: 36191334

Group type: EXPERIMENTAL
Intervention: Any analgesic administration
Number of subjects: 32463

Group type: EXPERIMENTAL
Intervention: Analgesic administration in African American patients
Number of subjects: 32463

Group type: COMPARATOR
Intervention: Analgesic administration in White patients
Number of subjects: 32463

Group type: COMPARATOR
Intervention: Analgesic administration in Hispanic patients
Number of subjects: 32463

Group type: EXPERIMENTAL
Intervention: Odds of nontreatment of pain for African American patients compared to White patients
Number of subjects: 32463

Group type: EXPERIMENTAL
Intervention: Odds of nontreatment of pain for female patients compared to male patients
Number of subjects: 32463
Study: 34001002

Group type: EXPERIMENTAL
Intervention: M207 3.8 mg (intracutaneous zolmitriptan)
Number of subjects: 335
Study: 32329160

Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (EQW)
Number of subjects: 468
Study: 35777122

Group type: COMPARATOR
Intervention: 400 IU/day of vitamin D3 supplementation
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 800 IU/day of vitamin D3 supplementation
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 1200 IU/day of vitamin D3 supplementation
Number of subjects: 116
Study: 33621762

Group type: EXPERIMENTAL
Intervention: Endoscopic butterfly cartilage myringoplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Microscopic butterfly cartilage myringoplasty
Number of subjects: 50
Study: 33068185

Group type: EXPERIMENTAL
Intervention: High-risk plaque MRI-based model (HRPMM) using radiomics features and machine learning
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combined model using both traditional and radiomics features
Number of subjects: 162

Group type: COMPARATOR
Intervention: Traditional model based on intraplaque hemorrhage and lipid-rich necrotic core
Number of subjects: 162
Study: 32412986

Group type: EXPERIMENTAL
Intervention: TFP block with 20 ml of 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline bilaterally
Number of subjects: 60
Study: 36165603

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives and menstrual cycle phases
Number of subjects: 340
Study: 33586212

Group type: EXPERIMENTAL
Intervention: Random coefficient regression models with possible missing data and variable follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size and study design planning using data from ADNI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Examination of drivers of variability
Number of subjects: 0
Study: 32554736

Group type: EXPERIMENTAL
Intervention: reverse TAP stenting
Number of subjects: 50

Group type: COMPARATOR
Intervention: DK-crush stenting
Number of subjects: 50
Study: 35798511

Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 35373947

Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted pelvic floor muscle training (PFMT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) alone
Number of subjects: 68
Study: 32019814

Group type: EXPERIMENTAL
Intervention: 1.8 µg of vitamin B12 daily for 6 months
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: 150 mg of folic acid daily for 6 months
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Both vitamin B12 and folic acid daily for 6 months
Number of subjects: 791

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 791
Study: 33524593

Group type: EXPERIMENTAL
Intervention: Standard-volume plasma exchange (SVPE), mean sessions 2.15 ± 1.42, median plasma volume replaced 5.049 L
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 40
Study: 33079901

Group type: EXPERIMENTAL
Intervention: Tri-Lock Bone-Preservation Stem
Number of subjects: 86

Group type: COMPARATOR
Intervention: Corail prosthesis
Number of subjects: 86
Study: 32916273

Group type: EXPERIMENTAL
Intervention: Maternal caffeine use during pregnancy
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Maternal vitamin use during pregnancy
Number of subjects: 1202
Study: 35986323

Group type: EXPERIMENTAL
Intervention: Atosiban (6.75 mg bolus intravenously 30 min before embryo transfer)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo (normal saline infusion)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 33887486

Group type: EXPERIMENTAL
Intervention: Histologically evaluated pancreatic fibrosis
Number of subjects: 261

Group type: COMPARATOR
Intervention: Surgically evaluated pancreatic texture
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Combination of fibrosis grade and pancreatic texture
Number of subjects: 261
Study: 32843005

Group type: EXPERIMENTAL
Intervention: Intervention (workshops and interviews to reduce physical and psychosocial load)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 450
Study: 34958809

Group type: EXPERIMENTAL
Intervention: 0.5 Gy single session LDRT along with standard pharmacologic therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard pharmacologic therapy alone
Number of subjects: 51
Study: 33684595

Group type: EXPERIMENTAL
Intervention: Continuous infusion of meropenem 3 g/24 h
Number of subjects: 600

Group type: COMPARATOR
Intervention: Bolus administration of meropenem 1 g q8h
Number of subjects: 600
Study: 34582678

Group type: EXPERIMENTAL
Intervention: OVCCA web application for health literacy promotion (6 weeks)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group received an activity package from the public health department
Number of subjects: 126
Study: 32334033

Group type: EXPERIMENTAL
Intervention: Hypofractionated WBI of 4256 cGy in 16 fractions over 22 days
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Conventional WBI of 5000 cGy in 25 fractions over 35 days
Number of subjects: 1152
Study: 34583887

Group type: EXPERIMENTAL
Intervention: Online course on healthy diet
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Online course on physical activity
Number of subjects: 37
Study: 33278031

Group type: EXPERIMENTAL
Intervention: Oil in water-based moisturizing product
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated site
Number of subjects: 0
Study: 32509290

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) treatment at 3 g/kg body weight three times daily for 10 days
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) treatment
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard-of-care for SAM
Number of subjects: 212
Study: 35612684

Group type: COMPARATOR
Intervention: Placebo (OP-PLA)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg.kg-1, OP-CAF)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Caffeine (OP-CAF)
Number of subjects: 11
Study: 33658054

Group type: EXPERIMENTAL
Intervention: Women with any role in decision-making
Number of subjects: 14032

Group type: EXPERIMENTAL
Intervention: Women with any formal education
Number of subjects: 14032

Group type: EXPERIMENTAL
Intervention: Women participating in any paid labor
Number of subjects: 14032

Group type: EXPERIMENTAL
Intervention: Women living in a household with another woman who uses modern contraception
Number of subjects: 14032

Group type: COMPARATOR
Intervention: Women living between 2 and 5 km from a primary health center
Number of subjects: 14032

Group type: COMPARATOR
Intervention: Women living between 5 and 10 km from a primary health center
Number of subjects: 14032
Study: 32446323

Group type: EXPERIMENTAL
Intervention: Comprehensive disease-modifying pharmacological therapy (ARNI, β blocker, MRA, SGLT2 inhibitor)
Number of subjects: 2737
Study: 35829656

Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg every four weeks
Number of subjects: 206
Study: 34217809

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35551878

Group type: EXPERIMENTAL
Intervention: Medication (methylphenidate)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 84

Group type: COMPARATOR
Intervention: Behaviour Management
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 84
Study: 34039390

Group type: EXPERIMENTAL
Intervention: Digital intervention for managing uncontrolled hypertension
Number of subjects: 125
Study: 34920045

Group type: COMPARATOR
Intervention: SGLT2 inhibitors
Number of subjects: 71545
Study: 32183779

Group type: EXPERIMENTAL
Intervention: Intervention to improve pediatric HIV care cascade focusing on patient tracking, active follow-up of defaulting patients, reduction in EID turn-around times for PCR results, and initiation of ART by nurses in child-at-risk services.
Number of subjects: 0
Study: 35666375

Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP before PDT (Group 1)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP 1 min after PDT (Group 2)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP before PDT (Group 3)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP 5 min after PDT (Group 4)
Number of subjects: 54
Study: 32256020

Group type: COMPARATOR
Intervention: rs111686806 in the HLA-A gene
Number of subjects: 382

Group type: COMPARATOR
Intervention: rs1055348 in the HLA-B gene
Number of subjects: 382

Group type: COMPARATOR
Intervention: rs202047044 in the HLA-DRB1 gene
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: HLA-B*35:01
Number of subjects: 382
Study: 33219694

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Infliximab (INF)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Etanercept (ETA)
Number of subjects: 487
Study: 33044249

Group type: EXPERIMENTAL
Intervention: Allogeneic pure PRP injection (4 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Corticosteroid injection (4 mL mixture of 1 mL of 40‐mg/mL triamcinolone acetonide and 3 mL of 2% lidocaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Corticosteroid injection (4 mL mixture)
Number of subjects: 60
Study: 35322520

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32281082

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (9 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine diabetes care (control group)
Number of subjects: 66
Study: 35481725

Group type: EXPERIMENTAL
Intervention: Executive Function (EF) training
Number of subjects: 70
Study: 33922552

Group type: EXPERIMENTAL
Intervention: Monitoring depth of anesthesia using Entropy and Surgical Pleth Index (SPI) values
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Fentanyl administration
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sevoflurane administration
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Noradrenaline administration
Number of subjects: 95
Study: 34255767

Group type: EXPERIMENTAL
Intervention: Treatment based on cerebrospinal fluid (CSF) analysis after lumbar puncture (LP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No lumbar puncture (LP)
Number of subjects: 96
Study: 35007642

Group type: EXPERIMENTAL
Intervention: Physical exercise program (3-4 times per week for 6 weeks, total 20 hours)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control program
Number of subjects: 52
Study: 33685394

Group type: EXPERIMENTAL
Intervention: Topical tissue adhesive (TA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard control (SC)
Number of subjects: 150
Study: 33331393

Group type: EXPERIMENTAL
Intervention: Autogenous bone graft (AB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bioactive glass (BG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bioactive glass + autogenous bone graft (BG + AB) 1:1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bio-Oss (BO)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bio-Oss + autogenous bone graft (BO + AB) 1:1
Number of subjects: 40
Study: 36006686

Group type: EXPERIMENTAL
Intervention: Short web‐based educational intervention about SR methodology
Number of subjects: 589

Group type: COMPARATOR
Intervention: PRISMA checklist
Number of subjects: 589
Study: 32731764

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 77
Study: 32122147

Group type: EXPERIMENTAL
Intervention: Water-exchange (WE) technique
Number of subjects: 46

Group type: COMPARATOR
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 46
Study: 35671521

Group type: EXPERIMENTAL
Intervention: Remote monitoring intervention
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group (test group itself)
Number of subjects: 1500
Study: 35034023

Group type: EXPERIMENTAL
Intervention: Titration group (Adinox® 25 mg aspirin/200 mg dipyridamole once daily for 2 weeks, then twice daily for 2 weeks)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Standard group (Adinox® twice daily for 4 weeks)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Aspirin 100 mg once daily for 4 weeks)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Titration group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Standard group
Number of subjects: 96
Study: 32753348

Group type: EXPERIMENTAL
Intervention: [U13C]linoleate
Number of subjects: 24

Group type: COMPARATOR
Intervention: [U13C]palmitate
Number of subjects: 24
Study: 35768786

Group type: EXPERIMENTAL
Intervention: Bayes‐theorem based risk prediction model implemented in hospitals
Number of subjects: 0
Study: 34274108

Group type: EXPERIMENTAL
Intervention: dTMS
Number of subjects: 125

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 125
Study: 33534403

Group type: EXPERIMENTAL
Intervention: 4 additional mastery level simulated performances
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 8 additional mastery level simulated performances
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0 additional mastery level simulated performances (Control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Initial assessment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Retention assessment
Number of subjects: 48
Study: 32108436

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 1000 U
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 1500 U
Number of subjects: 388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study: 33779360

Group type: EXPERIMENTAL
Intervention: PANSS‐6 ratings obtained via the SNAPSI
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Changes in PANSS‐6 total scores via the SNAPSI
Number of subjects: 77
Study: 33075261

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: DAPT (Dual Antiplatelet Therapy)
Number of subjects: 0
Study: 35762666

Group type: EXPERIMENTAL
Intervention: MM-SES-CD total score ≥26 at week 76
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Rutgeerts score at week 76
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: SES-CD ileum score at week 76
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: MM-SES-CD ileum score at week 76
Number of subjects: 208
Study: 33675664

Group type: EXPERIMENTAL
Intervention: Levofloxacin administration
Number of subjects: 45
Study: 32524934

Group type: EXPERIMENTAL
Intervention: Mothers' own high liking for sweet and savoury restricted foods and drinks
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Child high intake frequency at 5 years old
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Child early exposure
Number of subjects: 211
Study: 34075476

Group type: EXPERIMENTAL
Intervention: INFANT intervention
Number of subjects: 262
Study: 616063581

Group type: EXPERIMENTAL
Intervention: Neo dermal activator wound dressing
Number of subjects: 54

Group type: COMPARATOR
Intervention: Preoperative chemotherapy
Number of subjects: 54
Study: 36342435

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Misperceptions intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Empathetic listening control
Number of subjects: 150
Study: 34113085

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 2888

Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 2888

Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 2888

Group type: EXPERIMENTAL
Intervention: Pulse Pressure Index (PPI)
Number of subjects: 2888

Group type: EXPERIMENTAL
Intervention: Isolated abnormal SBP
Number of subjects: 2888

Group type: EXPERIMENTAL
Intervention: PP ≥50 mmHg
Number of subjects: 2888
Study: 32454920

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg intravenous bolus injection for 10 min before induction of anesthesia, followed by continuous infusion of 0.2‐0.4 μg/kg/h until the end of surgery, and 0.06 μg/kg/h for 5 days after surgery)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Saline (equal volumes)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 62
Study: 35612860

Group type: EXPERIMENTAL
Intervention: MORACS intervention (automatically triggered diagnostic support from tertiary hospital)
Number of subjects: 6249

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6249

Group type: EXPERIMENTAL
Intervention: MORACS intervention
Number of subjects: 6249

Group type: EXPERIMENTAL
Intervention: Missed STEMI diagnoses
Number of subjects: 6249

Group type: EXPERIMENTAL
Intervention: Accurately diagnosed STEMI
Number of subjects: 6249
Study: 35936363

Group type: EXPERIMENTAL
Intervention: Continuous psychological nursing based on grey clustering algorithm combined with pelvic floor muscle exercise
Number of subjects: 98

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 98
Study: 33284535

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2471

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 2471

Group type: EXPERIMENTAL
Intervention: Calibration curves for nomogram models
Number of subjects: 2471

Group type: EXPERIMENTAL
Intervention: ROC and DCA for nomogram performance
Number of subjects: 2471
Study: 34580858

Group type: EXPERIMENTAL
Intervention: Hydrodissection
Number of subjects: 46

Group type: COMPARATOR
Intervention: No hydrodissection (Control)
Number of subjects: 46
Study: 33203618

Group type: EXPERIMENTAL
Intervention: Oral beta blockade
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: ACEI/ARB
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Beta blocker and ACEI/ARB
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Neither ACEI/ARB nor beta blocker
Number of subjects: 3500
Study: 32644891

Group type: EXPERIMENTAL
Intervention: MCPP appliances
Number of subjects: 39

Group type: COMPARATOR
Intervention: GMD appliances
Number of subjects: 39